ATLASPropanc Biopharma (PPCB) earnings date: Nov 13, 2026
Propanc Biopharma (PPCB) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PPCB
| Last price | $1.84 (-12.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±9.5% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Propanc Biopharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Propanc Biopharma reports on Nov 13, 2026. One email the day before, with ATLAS’s read on Propanc Biopharma. You can switch it off at any time.
Alert me before PPCB reportsFree to start. Creating an account takes under a minute.
PPCB earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | May 20, 2026 · Beat |
| Beat rate (last 3 reports) | 3 of 3 (100%) |
| Average EPS surprise | +22.5% |
| Average move around a report | ±14.3% (last 3) |
| Sector | Healthcare · Biotechnology |
Propanc Biopharma earnings history: last 3 reports
Propanc Biopharma last reported on May 20, 2026: EPS of $3.09 against an estimate of $2.91 (+6.2% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| May 20, 2026 | $2.91 | $3.09 | +6.2% | Beat | -13.7% |
| Mar 17, 2026 | $0.42 | $0.65 | +54.8% | Beat | -14.0% |
| Oct 21, 2025 | $2.10 | $2.24 | +6.7% | Beat | -15.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PPCB
See the fair value, the probability range and the earnings history of Propanc Biopharma on its ATLAS page.
Propanc Biopharma (PPCB) stock analysisPlans from €3.99 a month.
Propanc Biopharma earnings: frequently asked questions
When does Propanc Biopharma (PPCB) report earnings?
Propanc Biopharma is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does PPCB beat earnings estimates?
Of its last 3 reports with a recorded result, Propanc Biopharma beat the EPS estimate 3 times; the average surprise was +22.5%. Past results do not predict the next one.
How much does PPCB move around earnings?
Over its last 3 reports the stock moved an average of 14.3% (absolute, from the close before the report day to the close after it), and finished higher 0 of 3 times.
Did Propanc Biopharma beat earnings estimates last quarter?
Propanc Biopharma last reported on May 20, 2026: EPS of $3.09 against an estimate of $2.91 (+6.2% surprise), a beat.
How much does PPCB usually move in a day?
On a normal trading day the ATLAS model puts PPCB’s one-day range at about ±9.5%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer